PNC Financial Services Group
PCRX icon

PNC Financial Services Group’s Pacira BioSciences PCRX Stock Holding History

PNC Financial Services Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.9K Sell
3,739
-12
-0.3% -$284 ﹤0.01% 2960
2026
Q1 		$84.8K Buy
3,751
+492
+15% +$10.9K ﹤0.01% 2924
2025
Q4 		$84.3K Buy
3,259
+297
+10% +$7.06K ﹤0.01% 2908
2025
Q3 		$76.3K Sell
2,962
-549
-16% -$13.5K ﹤0.01% 2974
2025
Q2 		$83.9K Buy
3,511
+531
+18% +$13.4K ﹤0.01% 2826
2025
Q1 		$74.1K Sell
2,980
-617
-17% -$14.8K ﹤0.01% 2861
2024
Q4 		$67.8K Buy
3,597
+513
+17% +$9.01K ﹤0.01% 2921
2024
Q3 		$46.4K Sell
3,084
-503
-14% -$8.6K ﹤0.01% 3132
2024
Q2 		$103K Sell
3,587
-4,853
-58% -$138K ﹤0.01% 2613
2024
Q1 		$247K Sell
8,440
-1,045
-11% -$32.1K ﹤0.01% 2026
2023
Q4 		$320K Buy
9,485
+2,387
+34% +$69.8K ﹤0.01% 1811
2023
Q3 		$218K Sell
7,098
-2,271
-24% -$81.9K ﹤0.01% 2061
2023
Q2 		$375K Sell
9,369
-9,600
-51% -$397K ﹤0.01% 1764
2023
Q1 		$774K Buy
18,969
+3,853
+25% +$153K ﹤0.01% 1266
2022
Q4 		$584K Sell
15,116
-8,238
-35% -$401K ﹤0.01% 1430
2022
Q3 		$1.24M Buy
23,354
+425
+2% +$23.6K ﹤0.01% 1019
2022
Q2 		$1.34M Buy
22,929
+3,059
+15% +$200K ﹤0.01% 1022
2022
Q1 		$1.52M Sell
19,870
-6,934
-26% -$462K ﹤0.01% 1044
2021
Q4 		$1.61M Buy
26,804
+2,027
+8% +$112K ﹤0.01% 1045
2021
Q3 		$1.39M Buy
24,777
+2,440
+11% +$141K ﹤0.01% 1041
2021
Q2 		$1.35M Buy
22,337
+2,655
+13% +$168K ﹤0.01% 1068
2021
Q1 		$1.38M Buy
19,682
+3,759
+24% +$269K ﹤0.01% 1031
2020
Q4 		$951K Sell
15,923
-1,167
-7% -$68.3K ﹤0.01% 1148
2020
Q3 		$1.03M Buy
17,090
+2,282
+15% +$133K ﹤0.01% 1035
2020
Q2 		$777K Sell
14,808
-831
-5% -$34.7K ﹤0.01% 1148
2020
Q1 		$525K Buy
15,639
+4,039
+35% +$168K ﹤0.01% 1261
2019
Q4 		$525K Sell
11,600
-33,516
-74% -$1.42M ﹤0.01% 1453
2019
Q3 		$1.72M Sell
45,116
-9,176
-17% -$366K ﹤0.01% 1043
2019
Q2 		$2.36M Buy
54,292
+25,591
+89% +$1.09M ﹤0.01% 951
2019
Q1 		$1.09M Sell
28,701
-10,706
-27% -$418K ﹤0.01% 1253
2018
Q4 		$1.7M Buy
39,407
+38,767
+6,057% +$1.81M ﹤0.01% 1055
2018
Q3 		$30K Sell
640
-227
-26% -$9.81K ﹤0.01% 3277
2018
Q2 		$29K Sell
867
-4,576
-84% -$158K ﹤0.01% 3303
2018
Q1 		$169K Sell
5,443
-2,376
-30% -$84.6K ﹤0.01% 2261
2017
Q4 		$357K Buy
7,819
+49
+0.6% +$1.94K ﹤0.01% 1840
2017
Q3 		$293K Buy
7,770
+911
+13% +$36.7K ﹤0.01% 1927
2017
Q2 		$328K Sell
6,859
-809
-11% -$37.5K ﹤0.01% 1839
2017
Q1 		$351K Sell
7,668
-444
-5% -$19.2K ﹤0.01% 1816
2016
Q4 		$263K Buy
8,112
+1,399
+21% +$46.7K ﹤0.01% 1963
2016
Q3 		$231K Sell
6,713
-467
-7% -$18.3K ﹤0.01% 2007
2016
Q2 		$242K Buy
7,180
+1,965
+38% +$96.6K ﹤0.01% 1963
2016
Q1 		$277K Buy
5,215
+1,647
+46% +$96.3K ﹤0.01% 1894
2015
Q4 		$273K Sell
3,568
-2,775
-44% -$157K ﹤0.01% 1889
2015
Q3 		$260K Sell
6,343
-2,100
-25% -$129K ﹤0.01% 1952
2015
Q2 		$598K Buy
8,443
+3,687
+78% +$290K ﹤0.01% 1529
2015
Q1 		$422K Buy
4,756
+4,360
+1,101% +$442K ﹤0.01% 1749
2014
Q4 		$35K Buy
396
+19
+5% +$1.8K ﹤0.01% 2941
2014
Q3 		$37K Buy
377
+41
+12% +$3.99K ﹤0.01% 2829
2014
Q2 		$31K Hold
336
– – ﹤0.01% 2761
2014
Q1 		$23K Sell
336
-164
-33% -$11.2K ﹤0.01% 2806
2013
Q4 		$29K Sell
500
-250
-33% -$13.1K ﹤0.01% 2692
2013
Q3 		$36K Buy
+750
New +$27.3K ﹤0.01% 2615

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PNC Financial Services Group's PCRX Position: Q2 2026 in Review

PNC Financial Services Group reduced its Pacira BioSciences (PCRX) stake by 0.32% in Q2 2026, selling an estimated $284 and leaving 3,739 shares worth $94.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2960.

PNC Financial Services Group first reported a position in PCRX in Q3 2013 and has held it in 52 quarters since. The position peaked at $2.36M in Q2 2019. 111 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • PNC Financial Services Group held 3,739 shares of Pacira BioSciences worth $94.9K as of Q2 2026.
  • PNC Financial Services Group sold 12 Pacira BioSciences shares in Q2 2026, an estimated $284.
  • Pacira BioSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2960 holding.
  • PNC Financial Services Group first reported a position in Pacira BioSciences in Q3 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Pacira BioSciences position peaked at $2.36M in Q2 2019.
  • 111 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.